文献速递胸部肿瘤放疗消化道肿瘤放疗放疗物理与技术

预测食管癌放疗患者放射性肺炎的新型列线图与风险分类系统

A Novel Nomogram and Risk Classification System Predicting Radiation Pneumonitis in Patients With Esophageal Cancer Receiving Radiation Therapy.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2019-08-25

本研究基于两家机构416例食管癌放疗患者回顾性数据,构建预测重度急性放射性肺炎(SARP)的列线图并做内外部验证,列线图一致性指数0.852,并据此建立三组风险分类系统。

要点

  • 列线图纳入SGA评分、肺纤维化评分、PTV/全肺体积、平均肺剂量和4周SII变化比。
  • 列线图C指数0.852,优于对照范围0.604-0.712,校准与决策曲线表现良好。
  • 风险分类系统将患者分为低危(6.1%)、中危(37.3%)和高危(78.9%)三组。

核心结论

  • SGA评分、肺纤维化评分、PTV/全肺体积、平均肺剂量及治疗4周时SII变化比是预测SARP的潜在有价值标志物。
  • 所构建列线图与风险分类系统对SARP具有较强预测能力,可辅助患者咨询和治疗决策。

研究设计与样本

  • 回顾性收集2家参与机构共416例接受放疗的食管癌患者数据。
  • 基于logistic回归分析构建预测SARP的新型列线图。
  • 采用一致性指数、校准曲线和决策曲线分析进行内部与外部验证。
  • 通过递归分割分析生成相应风险分类系统。

主要发现

  • 列线图预测SARP的一致性指数为0.852,对照范围0.604-0.712。
  • 校准曲线显示列线图预测与实际结局一致性良好。
  • 决策曲线分析显示满意的临床实用性。
  • 风险分类系统将患者完美分为3组:低危组6.1%(评分0-158)、中危组37.3%(评分159-280)、高危组78.9%(评分>280)。

关键数值与推荐

  • 列线图纳入的独立预测因子:SGA评分、肺纤维化评分、PTV/全肺体积、平均肺剂量、治疗4周时SII变化比。
  • 风险分类评分阈值:0-158为低危,159-280为中危,>280为高危。

临床怎么用

  • 可利用列线图对食管癌放疗患者进行SARP个体化风险评估。
  • 根据风险分类系统识别高危患者,辅助患者咨询与治疗决策。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We initially aimed to ascertain the application value of inflammatory indexes in predicting severe acute radiation pneumonitis (SARP). Furthermore, a novel nomogram and risk classification system integrating clinicopathologic, dosimetric, and biological parameters were built to provide individualized risk assessment and accurate prediction of SARP in patients with esophageal cancer who received radiation therapy. METHODS AND MATERIALS: All data were retrospectively collected from 416 esophageal cancer patients in 2 participating institutes. A novel nomogram was constructed that forecasted SARP based on logistic regression analyses. The concordance index, calibration curves, and decision curve analyses were used by both internal and external validation to demonstrate discriminatory and predictive capacity. Moreover, a corresponding risk classification system was generated by recursive partitioning analysis. RESULTS: The Subjective Global Assessment score, pulmonary fibrosis score, planning target volume/total lung volume, mean lung dose, and ratio of change regarding systemic immune inflammation index at 4 weeks in the course of treatment were independent predictors of SARP and finally incorporated into our nomogram. The concordance index of nomogram for SARP prediction was 0.852, which showed superior discriminatory power (range, 0.604-0.712). Calibration curves indicated favorable consistency between the nomogram prediction and the actual outcomes. Decision curve analyses exhibited satisfactory clinical utility. A risk classification system was established to perfectly divide patients into 3 different risk groups, which were low-risk group (6.1%, score 0-158), intermediate-risk group (37.3%, score 159-280), and high-risk group (78.9%, score >280). CONCLUSIONS: The Subjective Global Assessment score, pulmonary fibrosis score, planning target volume/total lung volume, mean lung dose, and ratio of change regarding systemic immune inflammation index at 4 weeks were potential valuable markers in predicting SARP. The developed nomogram and corresponding risk classification system with superior prediction ability for SARP could assist in patient counseling and provide guidance when making treatment decisions.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Wang L, Liang S, Li C, et al. A Novel Nomogram and Risk Classification System Predicting Radiation Pneumonitis in Patients With Esophageal Cancer Receiving Radiation Therapy. Int J Radiat Oncol Biol Phys. 2019. PMID: 31461673. doi:10.1016/j.ijrobp.2019.08.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。